No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"

Travel Med Infect Dis. 2020 Jul-Aug:36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Azithromycin
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / drug therapy
  • France
  • Humans
  • Hydroxychloroquine
  • Pandemics*
  • Pneumonia, Viral*
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Azithromycin